...
首页> 外文期刊>Open Chemistry >Validated thin-layer chromatographic method for alternative and simultaneous determination of two anti-gout agents in their fixed dose combinations
【24h】

Validated thin-layer chromatographic method for alternative and simultaneous determination of two anti-gout agents in their fixed dose combinations

机译:验证薄层色谱法,用于替代和同时测定其固定剂量组合中的两种抗痛风剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A rapid, simple and sensitive thin-layer chromatography (TLC) spectrodensitometric method was developed for the simultaneous determination of colchicine and probenecid in their binary mixtures. The two drugs were quantitatively separated using silica gel 60 F^ as stationary phase and toluene-ethyl acetate-methanol-ammonia (30:20:20:0.1, v/v/v/v) as mobile phase with UV detection at 248 nm for both drugs and at 354 nm for colchicine alone. Both drugs were efficiently separated with Rf values of 0.33±0.03 and 0.60±0.03 for probenecid and colchicine, respectively. The linearity was found to be 16-320 and 120-2400 (ng/band) with quantitation limits of 17.59 and 225.82 ng/band for colchicine and probenecid, respectively, at 248 nm. At 354 nm, the linearity range of colchicine was found 16-240 ng/band with a quantitation limit of 54.03 ng/band. The experimental determination ranges were greatly extended with lower quantitation limits (15.60 and 116.13 ng/band for colchicine and probenecid, respectively at 248 nm, and 13.20 for colchicine at 354 nm) and correlation coefficients were improved when polynomial regression analysis was used. The quadratic model was found to be the best fit for all responses. The method has been validated according to the International Conference on Harmonization (ICH) guidelines providing good correlation coefficients (0.9997-0.9999) for both drugs, and it has been successfully applied in the determination of both drugs in their commercial dosage form without interference from excipients.
机译:开发了一种快速,简单敏感的薄层色谱(TLC)光囊型方法,用于同时测定其二元混合物中的血清序列和丙烯酸。用硅胶60f ^定量分离两种药物作为固定相和甲苯 - 乙酸乙酯 - 甲醇 - 氨(30:20:20:0.1,v / v / v / v),在248nm处具有UV检测的流动相单独用于血清腺的药物和354nm。对于丙烯酸和血清曲线,两种药物以0.33±0.03和0.60±0.03的RF值有效地分离。线性度被发现为16-320和120-2400(NG / BAND),定量限制为17.59和225.82ng / brand,分别在248nm处分别用于血氯氨酸和丙烯酸。在354nm处,发现了16-240ng /波段的秋水仙碱的线性范围,定量限为54.03 ng /波段。实验测定范围大大延伸,定量限制较低(15.60和116.13ng / broun for Colcinicine和丙烯酸,在248nm处,在354nm的354nm处,在354nm下进行13.20),并且当使用多项式回归分析时,改善了相关系数。发现二次模型是所有反应的最适合。该方法已根据国际协调会议(ICH)指南提供良好的相关系数(0.9997-0.9999),用于两种药物,并已成功地应用于其商业用量形式的两种药物,而不会干扰赋形剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号